Inspiring people, place, and purpose Inspiring people, place, and purpose Penn President Amy Gutmann’s record tenure of nearly 18 years is the University’s most transformative.
Addressing substance use and pain key to limiting self-directed hospital discharge Addressing substance use and pain key to limiting self-directed hospital discharge A new study from the School of Nursing suggests that stigma toward persons with substance abuse disorder may account for an under-assessment and management of pain, which leads to self-directed patient discharges.
The origins of the opioid epidemic The origins of the opioid epidemic The study, “Origins of the Opioid Crisis and its Enduring Impacts” examines the role of the 1996 introduction and marketing of OxyContin as a potential leading cause of the opioid crisis.
Why does alcohol mess with my sleep? Penn In the News The New York Times Why does alcohol mess with my sleep? Ilene M. Rosen of the Perelman School of Medicine said alcohol is a sedative and should not be combined with sleep aids. “I would not use any sedative hypnotic, whether over-the-counter or not, when you’re drinking alcohol,” she said. First-in-human trial with CAR macrophages shows promise targeting solid tumors First-in-human trial with CAR macrophages shows promise targeting solid tumors A new Penn study demonstrates that engineered macrophages, which can be targeted to tumors, may be a possible new immune-based treatment of some cancers. Racial disparity in follow-up appointments disappears with telemedicine Racial disparity in follow-up appointments disappears with telemedicine An inequity in the rate of Black patients making it to their primary care appointment after a hospitalization was eliminated after telemedicine became widely used amid the COVID-19 pandemic. Busting myths about the Asian American ‘model minority’ Busting myths about the Asian American ‘model minority’ Two new studies highlight the problem with aggregating diverse groups of people into a single category of “Asian American” when applied to cardiovascular disease and cancer diagnosis and outcomes. A new method to increase effectiveness of nanomedicines Upon injection into the blood, nanomedicines (blue spheres) are immediately attacked by proteins of the immune system called complement proteins (orange). Complement proteins cause rapid destruction of the nanomedicine, and also induce an anaphylaxis-like reaction. By attaching complement-degrading proteins (yellow ninjas made of protein) to the surface of nanomedicines, Penn researchers have largely solved this problem, potentially allowing more diseases to be safely treated by nanomedicine.(Image: Penn Medicine News) A new method to increase effectiveness of nanomedicines Penn Medicine researchers have developed a new technique that uses complement inhibitor Factor I to prevent proteins from attacking treatment-carrying nanoparticles so they can better reach targets within the body. Wearables can predict near-term blood sugar control in prediabetes patients Wearables can predict near-term blood sugar control in prediabetes patients Penn researchers find that using wearable devices, especially those on the wrist, and machine learning approaches could predict blood sugar control. Researchers find new potential targets for skin-cancer treatment Researchers find new potential targets for skin-cancer treatment Making up for the genetic mutations of MLL4 in skin cells, one of the most commonly mutated genes across all of human cancers, may keep epithelial cancer from beginning and progressing
First-in-human trial with CAR macrophages shows promise targeting solid tumors First-in-human trial with CAR macrophages shows promise targeting solid tumors A new Penn study demonstrates that engineered macrophages, which can be targeted to tumors, may be a possible new immune-based treatment of some cancers.
Racial disparity in follow-up appointments disappears with telemedicine Racial disparity in follow-up appointments disappears with telemedicine An inequity in the rate of Black patients making it to their primary care appointment after a hospitalization was eliminated after telemedicine became widely used amid the COVID-19 pandemic.
Busting myths about the Asian American ‘model minority’ Busting myths about the Asian American ‘model minority’ Two new studies highlight the problem with aggregating diverse groups of people into a single category of “Asian American” when applied to cardiovascular disease and cancer diagnosis and outcomes.
A new method to increase effectiveness of nanomedicines Upon injection into the blood, nanomedicines (blue spheres) are immediately attacked by proteins of the immune system called complement proteins (orange). Complement proteins cause rapid destruction of the nanomedicine, and also induce an anaphylaxis-like reaction. By attaching complement-degrading proteins (yellow ninjas made of protein) to the surface of nanomedicines, Penn researchers have largely solved this problem, potentially allowing more diseases to be safely treated by nanomedicine.(Image: Penn Medicine News) A new method to increase effectiveness of nanomedicines Penn Medicine researchers have developed a new technique that uses complement inhibitor Factor I to prevent proteins from attacking treatment-carrying nanoparticles so they can better reach targets within the body.
Wearables can predict near-term blood sugar control in prediabetes patients Wearables can predict near-term blood sugar control in prediabetes patients Penn researchers find that using wearable devices, especially those on the wrist, and machine learning approaches could predict blood sugar control.
Researchers find new potential targets for skin-cancer treatment Researchers find new potential targets for skin-cancer treatment Making up for the genetic mutations of MLL4 in skin cells, one of the most commonly mutated genes across all of human cancers, may keep epithelial cancer from beginning and progressing